Unicycive Therapeutics Inc. (UNCY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,401,447 | $6,572,786 | +50% | 0.21% |
| 2. | Octagon Capital Advisors Ting Jia | 1,000,000 | $4,690,000 | 0.42% | |
| 3. | 792,600 | $3,717,294 | 0.47% | ||
| 4. | Vivo Capital Albert Cha And Frank Kung | 550,000 | $2,579,500 | -70% | 0.24% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 547,862 | $2,569,473 | +254% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.83 | 15,000 | $12,375.00 | 15,000 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,413,381 | $6,628,757 | 0% | |
| 2. | 1,071,481 | $5,025,246 | 0% | |
| 3. | 564,019 | $2,646,043 | 0% | |
| 4. | 450,162 | $2,111,260 | 0% | |
| 5. | 420,000 | $1,969,800 | 0.01% |
Hedge Fund Resource Center